Virginia Retirement Systems Et Al Cue Biopharma, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	SELL	$2.23 - $3.37 $24,530 - $37,070	-11,000 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$4.41 - $12.28 $22,050 - $61,400	-5,000 Reduced 31.25%	11,000 $54,000
Q4 2021 Feb 03, 2022	BUY	$10.86 - $17.85 $39,096 - $64,260	3,600 Added 29.03%	16,000 $181,000
Q3 2021 Oct 21, 2021	BUY	$10.06 - $15.3 $16,096 - $24,480	1,600 Added 14.81%	12,400 $181,000
Q2 2021 Aug 13, 2021	BUY	$10.9 - $14.53 $117,720 - $156,924	10,800 New	10,800 $126,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.